COLUMBIA — State health officials estimate more than 1,000 hospital admissions for COVID-19 have been avoided through a monoclonal antibody program.

The U.S. Food and Drug Administration (FDA) approved antibody infusions in November for emergency use to treat patients who had specific health issues, including those with a body mass index greater than 35, those affected by diabetes, chronic kidney disease, immunosuppressive disease and/or taking immunosuppressive medication, and those older

You must be logged in to view this content.